Hyponatremia due to inappropriate secretion of vasopressin is a common disorder in human pathophysiology, but vasopressin synthesis during hypoosmolality has not been investigated. We used a new method to quantitate synthesis of vasopressin in rats after 3, 7, and 14 d of hyponatremia induced by administering dDAVP (a vasopressin agonist) and a liquid diet. Vasopressin synthesis was completely turned off by 7 d. Vasopressin mRNA levels in the hypothalamus paralleled the reduction in synthesis and were reduced to levels of only 10-15% of the content in control rats. When hyponatremia was corrected by withdrawal of dDAVP, vasopressin mRNA slowly returned to normal over 7 d. The observation that vasopressin synthesis can be so completely turned off leads to several conclusions: under normal physiological conditions the neurohypophysis is chronically upregulated; there must be an osmotic threshold for initiation of vasopressin synthesis (and release); the large store of hormone in the posterior pituitary is essential for vasopressin to be available during times of decreased synthesis; and, finally, some nonosmolar stimulus for synthesis must be present during clinical disorders when vasopressin is secreted (and synthesized) despite hypoosmolality. (J. Clin. Invest.
Introduction
Hyponatremia is a common clinical problem with reported incidences of 2.5-22% of hospitalized patients (1) (2) (3) . It is frequently thought to be due to (or associated with) elevated secretion of arginine vasopressin, a hormone that is synthesized in the supraoptic and paraventricular nuclei ofthe hypothalamus and is transported to, stored in, and released from the posterior pituitary. The hormone acts on the kidney to increase permeability of water in the collecting duct to cause water retention. With hyperosmolality and/or decreased volume, vasopressin secretion is stimulated, but with hypoosmolality and/or expanded volume, vasopressin secretion is suppressed (4) . In many clinical situations of chronic hyponatremia, secretion of vasopressin is not suppressed, but secreted inappropriately relative to plasma osmolality. Thus, in these situations it appears that vasopressin secretion (and synthesis?)
is not downregulated appropriate to the serum Na'. Other physiologic observations also indicate that the neurohypophysis may not readily downregulate its synthesis of vasopressin. The major reason to shut off vasopressin synthesis and secretion is to produce maximum water diuresis. However, since maximum water diuresis is achieved at levels of vasopressin of 0.3-0.5 pg/ml, animals may not need to completely inhibit synthesis and release of vasopressin to permit maximum diuresis (5) . Furthermore, vasopressin mRNA levels become elevated two-to fivefold in hypernatremic rats, but when the elevated serum Na+ returns to normal the vasopressin mRNA only sluggishly decreases over 2-4 wk (6) (7) (8) , suggesting relative insensitivity of synthesis to the decrease in osmolality.
In contrast to reports documenting the response of the neurohypophysis to hypernatremia (6) (7) (8) , there are few studies of the response of the neurohypophysis to hyponatremia, when secretion of vasopressin is decreased. This is in part because there has been no stable model of long-term hyponatremia in an experimental animal. Humans given excess vasopressin and ad lib. water will develop hyponatremia (9) , but rats given vasopressin will decrease water intake and thereby maintain a normal serum sodium concentration (10) . To induce acute and chronic hyponatremia in the rat has required administration of vasopressin along with continuous fluid loading by parenteral administration of a hypotonic solution (11) . However, one of us (J. G. Verbalis) recently described a protocol in which rats developed and maintained self-induced hyponatremia for long periods during chronic administration ofa vasopressin agonist, dDAVP, ifthe rats were given a dilute liquid nutrient as their only source of calories (10, 12) . We used this model to study downregulation of vasopressin synthesis in the supraoptic (SON) and paraventricular (PVN) nuclei during hyponatremia and documented that synthesis of vasopressin was turned off. We also studied oxytocin, the other major hormone of the neurohypophysis. Although in most species there is only sporadic need for oxytocin to regulate parturition and lactation (13) , in the rat oxytocin is secreted similarly to vasopressin in response to changes in serum osmolality and blood volume (14) . Synthesis of oxytocin decreased similarly during hyponatremia, confirming parallel responses of both neurohypophyseal hormones to hypoosmolality as well as hyperosmolality. Hypoosmolality was induced using previously described methods (12) . The rats were acclimated to a commercial, nutritionally balanced liquid diet formulated for rodents (AIN-76; Bio-Serv, Frenchtown, NJ) modified to provide 1.9 kcal/ml. For most days the modified diet was provided in liquid feeding tubes at 50 ml/d, which was calculated to be a weight-maintenance diet. After 3-4 d of the liquid diet, osmotic minipumps (model 2002; Alzet Corp., Palo Alto, CA) containing dDAVP' (desmopressin at a 0.01% intranasal solution; Rorer Pharmaceuticals, Fort Washington, PA) diluted in 0.15 M NaCl to a concentration of 10 g/ml were implanted subcutaneously along the back under methoxyflurane (Metophane; Pittman-Moore) inhalation anesthesia, resulting in a dDAVP infusion rate of 5 ng/h. On the first day after insertion of the minipumps, the rats were given 100 ml of a 1.0 kcal/ml formulation of the liquid diet. From day 2 onward of dDAVP infusion the rats were given 50 ml ofthe modified concentrated diet as a single morning feeding. Some rats received an identical dDAVP infusion but were maintained on ad lib. water and pelleted rat chow while others were placed on the identical liquid diet but received no dDAVP.
Methods
Measured synthesis of vasopressin and oxytocin. Vasopressin is synthesized in the magnocellular neurons of the supraoptic and paraventricular nuclei of the hypothalamus and transported to the posterior pituitary via microtubules (15) . Colchicine is well known to disrupt microtubular transport and we recently reported that low doses of colchicine injected into the third ventricle of the hypothalamus of rats blocked transport of vasopressin while synthesis continued (16 7 ,ug, was injected in 1 M1 0.15 M NaCl at a rate of 0.1 l every 10 s. After injection, the hole in the skull was sealed with bone wax (Ethicon, Somerville, NJ), the skin was closed with clips, and the animals were kept warm until they recovered from anesthesia when they were returned to their cages. As reported previously (16) , with this dose of colchicine animals awoke from anesthesia normally and showed no change in behavior. Published studies have documented a linear accumulation of vasopressin and oxytocin in the hypothalamus of control animals from 0 to 18 h after injection (16) . Groups of rats were killed at 0 h of colchicine injection and 12-18 h after injection of colchicine. Synthesis rate of hormone was determined by the difference in content of hormone in the hypothalamus at the two time points divided by the number of hours of blocked transport. The hourly rate of synthesis with this method in normal rats is 1.2-1.9 pmol/h for vasopressin, 1.4-2.5 pmol/h for oxytocin, and 3.8-4.3 pmol/h for neurophysin (16) .
Tissue extraction. After the mice were decapitated the skin overlying the skull was removed and the skull was cut with scissors. The brain was lifted to expose the optic nerves which were cut and the brain was then removed, inverted, and placed in a modified Jacobowitz slicer ( 17) (Zivic Miller Laboratories). Vertical razor blade cutsjust rostral to the optic chiasm and just rostral to the mammillary bodies were made and this thick section of hypothalamus laid on a sterile petri dish. For assay of peptides, freehand cuts were made at the top of the third ventricle and lateral of the hypothalamic sulci to produce a wedge of hypothalamus containing all of the supraoptic nuclei and paraventricular nuclei and the tracts to the pituitary stalk. Each individual wedge of hypothalamus was homogenized in a ground glass tissue homoge-1. Abbreviations used in this paper: dDAVP, desmopressin; PVN, paraventricular nuclei; SON, supraoptic nuclei. nizer with I ml 0.1 normal HCI at 4VC with an additional 1 ml used to rinse the pestle and homogenizer.
For extraction of mRNA the brain was handled similarly with the exception that in addition to the razor blade at the optic chiasm and anterior to the mammillary bodies, a third razor blade was lowered to bisect this section of hypothalamus. The two slices of hypothalamus were laid open on a petri dish in an open-book fashion and using a razor blade the two supraoptic nuclei and paraventricular nuclei were cut out free hand. The remaining sections have been confirmed to contain no supraoptic or paraventricular magnocellular nuclei by immunohistology. Similar methods have been published to demonstrate up regulation of vasopressin mRNA with hyperosmolality in rats (18) . The paired supraoptic nuclei and paraventricular nuclei were dropped into plastic snap-top vials (Fisher Scientific, Pittsburgh, PA) quick frozen on dry ice, and stored at -70°overnight for extraction the next day.
RIAs. Acid extracts of tissue were appropriately diluted in 0.1 M phosphate buffer pH 7.4 and assayed at multiple dilutions. Plasma was either collected from trunk blood or (for repeat samples) from an indwellingjugular venous catheter. Silastic tubing (1.19 mm o.d.; Dow Corning, Midland, MI) was inserted into the jugular vein to the level of the right atrium and connected to a link ofpolyethylene tubing (PE-60; Clay Adams Div., Parsippany, NJ) that was tunneled to an opening in the skin between the scapulas. The catheter was filled with providoneheparin solution (Eastman Kodak Co., Rochester, NY) which was removed and the catheter flushed with 0.15 M NaCI 30-60 min before drawing a blood sample. Blood samples of 1-1.5 ml were withdrawn over 15-30 s into disposable plastic syringes and immediately transferred to iced borosilicate tubes containing 143 U heparin (BD vacutainer, Rutherford, NJ). Blood removed was replaced with an equal volume of 0.15 M NaCl with packed red blood cells from the sample.
Plasma samples for oxytocin and vasopressin were extracted as previously described and measured with RIAs established in our laboratory (19, 20) . The assay for rat neurophysin measures total neurophysin and is not specific for vasopressin/neurophysin or oxytocin/ neurophysin (21) . Blood samples for Na' determination were centrifuged at 4VC and the plasma removed for plasma sodium measured on an electrolyte 2 analyzer (Beckman Instrument Co., Fullerton, CA).
Quantitation of mRNA. Solution hybridization was performed as previously described (18) . Tissue biopsies of supraoptic and paraventricular nuclei were homogenized in 0.3 ml LET buffer (10 mM TrisHCl, PH (18) . The concentration of AVP mRNA was calculated using optical density determined by a Loats image analysis system. Optical density was correlated with actual disintegrations per minute of clean bands that could be scraped from the glass plate, hydrolyzed, neutralized and counted in scintillation vials. The correlation of optical density and disintegrations per minute was r > 0.995. Disintegrations per minute were converted to mole equivalents based on specific activity of the cRNA probe, the frequency of labeled nucleotide, and the deduced sequence of the protected cRNA band (18) . Results are expressed as total mRNA per rat.
Results
Hyponatremia. Stable hyponatremia was demonstrated in 11 rats treated for 14 d with dDAVP and liquid diet, while vehicle-treated controls on the same diet had no change in serum sodium (Fig. 1) . Plasma sodium in the 24 experimental rats used to quantitate synthesis of vasopressin on days 0, 3, 7, and 14 of hyponatremia are also illustrated in Fig. 1 . Baseline sodium in rats at day 0 was 140.6±0.3 mmol/liter and the range of serum sodium in all experimental rats was between 108 and 115 mmol/liter. Experimental rats were significantly hyponatremic relative to controls at all time points tested after day 0 (P < 0.01). Hyponatremic rats maintained their weight over the 14 d: 294±3 g at day 0, and 307±3, 302±3, and 312±3 g at 3, 7, and 14 d of hyponatremia, respectively. For 24 rats given liquid diet without dDAVP, serum Na' at day 14 was 141±0.9 mmol/liter, a value not different from control rats. Weights at day 0 and 14 were 309±3 and 331±2 g. For 24 rats given dDAVP but ad lib. diet serum Na' at day 14 was 137±0.5 mmol/liter, slightly less than control, P < 0.01. These rats on ad lib. diet gained more weight than the other groups over the 14 d, increasing from 298±2 to 461±3 g.
Synthesis of neurohypophyseal peptides. Hourly synthesis of vasopressin, oxytocin and neurophysin at 0, 3, 7, and 14 days of hyponatremia is illustrated in Fig. 2 . As previously described (16) , synthesis rates were determined by comparing mean hypothalamic peptide at baseline versus content postcolchinine blockade. These two means were significantly different by t test P < 0.05 for vasopressin at day 0 and 3 and for both oxytocin and neurophysin at day 0, 3, and 14 Fig. 1 ). Quantitation of neurohypophyseal mRNA. Vasopressin and oxytocin mRNA were measured in rats maintained as above and decapitated after 0, 3, 7, and 14 d of hyponatremia. Samples from individual rats' supraoptic and paraventricular nuclei were run on polyacrylamide gels in groups of four to include sequentially a 0-, 3-, 7-, and 14-d rat. An autoradiograph of hybridized vasopressin mRNA samples from the supraoptic nuclei is illustrated in Fig. 3 . A decrease in vasopressin mRNA is apparent at 3 d and there was a further decrease at 7 and 14 d of hyponatremia. Of interest is the mRNA ofthe rats to the right of Fig. 3 in which the 7-and 14-d hyponatremic rats did not show the same decreased vasopressin mRNA. These two rats both had normal plasma sodium values at killing, probably due to malfunction of the osmotic minipump that was used to infuse the dDAVP. They do, however, augment the data on the dietary controls shown earlier and demonstrate that forced fluid intake alone was not sufficient to produce downregulation of vasopressin mRNA in the absence of hyponatremia.
Neurophysins are part of the precursor hormone for vasopressin and oxytocin and although the neurophysins are hormone specific, they are identical in the midportion (exon B) of the prohormones (18) . As the riboprobe used in the study was a near full-length vasopressin riboprobe, there is hybridization in solution to the midportion of the oxytocin mRNA, but there is only a partial match for oxytocin so the resulting dimer is shorter and less radioactive. The However, for quantitation of oxytocin a full-length riboprobe for oxytocin was used and in these gels (not shown) the relative positions of the oxytocin mRNA and the vasopressin mRNA were reversed.
The percentage change of vasopressin mRNA in the supraoptic and paraventricular nuclei is illustrated in Fig. 4 . There was a > 50% reduction in vasopressin mRNA by the third day and > 85% reduction by day 14. Vasopressin mRNA in the paraventricular nucleus showed a pattern similar to the supraoptic nucleus although the total content was less. At baseline the vasopressin mRNA content in the supraoptic nuclei was 281.3±13.6 (X 10-18 mol) while in the paraventricular nuclei it was 50.9±15.8 (X 10-18 mol) consistent with previous reports that the SON To determine how long the mRNA would remain decreased when the hyponatremia was reversed, rats were made similarly hyponatremic for 7 d and then the infusion of dDAVP was terminated by removing the pumps and the diet was changed to ad lib. access to pelleted rat chow and water. With this paradigm serum Na+ returns to normal in 24-48 h (12) , and all of the rats in this study achieved a normal serum Na+ by killing. Vasopressin and oxytocin mRNA was quantitated at 7 d of hyponatremia (which is considered day 0 of recovery) and also at 2, 4, and 7 d of recovery. Total hypothalamic vasopressin mRNA (supraoptic nucleus + paraventricular nucleus) expressed as a percentage of basal was: 17±2 at day 0 (n = 5); 33±6 at day 2 (n=4); 67±8 at day 4(n= 5); and 86±11% at day 7 (n = 3). For oxytocin mRNA the values were: 56±6 at day 0; 69±3 at day 2; 60+4 at day 4; and 84±7% at day 7 .
Discussion
These studies demonstrate that with decreased need for vasopressin secretion there is decreased vasopressin synthesis. This was a physiologic response to the hyponatremia because synthesis of vasopressin was not decreased by administration of dDAVP alone nor with the liquid diet alone. Interestingly, some studies have indicated that the natural hormone, AVP, i " *'0 inhibits recovery of damaged vasopressinergic neurons independent of osmolality (23, 24) , and a modest decrease in mRNA has been reported with vasopressin infusion (25) . We saw no effect of dDAVP alone to decrease vasopressin synthe- In the studies in which hyponatremic rats were allowed to recover from the hypoosmolality, vasopressin mRNA returned to normal only slowly over 7 d. This is similar to studies of normonatremic rats made hypernatremic, in which vasopressin mRNA was not significantly elevated until 36-48 h (6) (7) (8) . These various observations can be interpreted to provide an explanation for the large store of hormone in the posterior pituitary. This store allows the animal to satisfy acute needs for vasopressin by releasing preformed hormone during the time it takes to initiate transcription and to increase translational activity.
The data reported here also lend support to the concept of an osmotic threshold for vasopressin release. Based on measurement of plasma vasopressin levels, it has been debated whether there was a discrete osmotic threshold for release of vasopressin or whether there was a logarithmic relationship between plasma osmolality and plasma vasopressin release (33) (34) (35) . In the latter case, one would expect that vasopressin secretion, and hence synthesis, would never be completely turned off. However, the data presented here indicate that vasopressin synthesis can be turned off, thus providing support on a molecular level for the concept of an osmotic threshold.
With the knowledge that synthesis of vasopressin can be so dramatically decreased with hyponatremia, we suggest that a normal rat, which maintains easily measurable vasopressin mRNA levels, must have a chronically stimulated (upregulated) system. This is consistent with the fact that all terrestrial animals are chronically threatened by dehydration and must maintain active secretion of vasopressin. This observation is also consistent with the idea that under normal conditions animals function in the midrange of their vasopressin/osmolality relationship, neither maximally stimulated nor maximally suppressed.
The physiologic role ofoxytocin in regulation ofosmolality in the rat has not been completely defined (14, 36) , but the studies reported here again demonstrate that in the rat, unlike other animals, there are changes in secretion, synthesis and transcription of oxytocin similar to that of vasopressin in response to changes in serum sodium concentration. The downregulation of oxytocin in our studies, like vasopressin, was likely a physiologic response to hyponatremia and not a pharmacologic response to dDAVP, because even when arginine vasopressin was reported to inhibit recovery of vasopres7 sinergic neurons in the studies noted above (23, 24) , the infusion did not inhibit the recovery of damaged oxytocinergic neurons.
The results reported here provide some insight into the common clinical problem of hyponatremia in which plasma vasopressin is elevated despite hypoosmolality. While inappropriate secretion of vasopressin has some well recognized causes, e.g., secretion of vasopressin by carcinoma of the lung (37); when the vasopressin secretion is from the neurohypophysis, the stimulus for secretion is often undetermined. Our findings that vasopressin synthesis (mRNA) is so completely downregulated by hypoosmolality indicate that to maintain transcription of message and translation of vasopressin requires some other ongoing excitatory stimulus. It is well recognized that the input to the neurohypophysis is bimodal (38-40) ; an osmotic input that primarily responds to plasma osmolality and a baroreceptor or volume receptor stimulus that includes high-pressure receptors sensing blood pressure and low-pressure receptors sensing plasma or extracellular fluid volume. The osmolar stimulus is generally considered to be more sensitive to small changes, but the volume receptor system is capable of producing higher plasma levels of vasopressin when maximally stimulated (38, 39, 41) . In clinical situations, when secretion of vasopressin is inappropriate to the hyponatremia there must also be some ongoing excitatory stimulus to override the downregulation that would otherwise be produced by the hyponatremia. One possible source ofsuch stimuli is baroreceptor or volume receptor activation. Indeed, in two large clinical studies of hyponatremia with excess vasopressin levels; renin levels and pulse indicated that there was "appropriate" baroreceptor stimulation of vasopressin (1, 42) . Similar baroreceptor stimulation was reported in specific reports of hyponatremia in cirrhosis (43) and congestive heart failure (44) . The experimental model of hyponatremia we used does not separate the two types of input because the hyponatremia in these rats is associated with volume expansion, so both osmotic-induced and volume-induced stimuli to vasopressin release should be inhibited ( 12, 41) . In future studies it will be of interest to determine which of these two inputs provides a stronger stimulus for vasopressin mRNA transcription, and whether baroreceptor stimulation will overcome the downregulation produced by hypoosmolality.
